Advertisement
Skip to Content

Bausch Health Companies Inc BHC Stock Quote

| Rating as of

NYSE: BHC

Last close prices updated as of Feb 07, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 7.69
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Mid Value
  • Day Range 7.55  –  7.96
  • Year Range 4.00  –  26.39
  • Market Cap 2.8370 Bil
  • Volume / Avg 2.6 Mil /  5.4 Mil
  • Price / Sales 0.34
  • Price / Book 18.78
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis BHC

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BHC

Company Profile BHC

Business Description

Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.

Contact
2150 Saint Elzear Boulvard West
Laval, QC, H7L 4A8, CAN
Industry Drug Manufacturers - Specialty & Generic
Employees 19,600

Related Articles BHC

FAQs for Bausch Health Companies Inc Stock

No. BHC does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BHC’s market cap is 2.84 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

BHC’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BHC’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BHC’s historical performance against its industry peers and the overall market.